New Covenant Trust Company »

Tg Therapeutics shares owned by New Covenant Trust Company

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by New Covenant Trust Company from 13F filings

Historical chart of New Covenant Trust Company investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by New Covenant Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by New Covenant Trust Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.5k 556 15.21

More positions owned by New Covenant Trust Company

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard World Esg Us Stk Etf (ESGV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard World Esg Intl Stk Etf (VSGX)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Ishares Tr Msci Usa Esg Slc (SUSA)
Amazon (AMZN)
Fidelity Covington Trust Fundamental Larg (FFLC)
Vanguard Index Fds Sm Cp Val Etf (VBR)

View all positions for New Covenant Trust Company

Top funds holding Tg Therapeutics

Vanguard Group
BlackRock
State Street Corporation
Soleus Capital Management
Pictet Asset Management Holding SA
Geode Capital Management
Wellington Management Company
Deep Track Capital
Susquehanna International
Citadel Advisors
Opaleye Management
Goldman Sachs Group
Bank of America Corporation
Marshall Wace
Sofinnova Ventures

View all funds holding Tg Therapeutics